Clarity Pharmaceuticals (ASX:CU6) Signs Copper-64 Supply Agreement with Nusano
Clarity Pharmaceuticals (ASX:CU6) secures a copper-64 supply agreement with Nusano to support clinical trials and commercialization.
Clarity Pharmaceuticals (ASX:CU6) secures a copper-64 supply agreement with Nusano to support clinical trials and commercialization.
Anatara Lifesciences (ASX:ANR) reports Phase II GaRP-IBS trial results, highlighting safety and significant improvements in anxiety scores.
Dreadnought Resources Ltd (ASX:DRE) closes its Share Purchase Plan, raising $1.73M with strong shareholder support.
West African Resources Limited (ASX:WAF) releases its quarterly cash flow report, highlighting key operational and financial metrics.
Podium Minerals (ASX:POD) completes the EV Nickel acquisition and becomes the first Australian PGM developer to join the World Platinum Investment Council.
Imricor Medical Systems (ASX:IMR) secures CE Mark approval for its Advantage-MR system under the new EU Medical Device Regulation, anticipating EU launch in June.
Tourism Holdings Limited (ASX:THL) updates FY25 trading outlook, projecting lower NPAT due to decreased bookings and vehicle sales demand.
Streamplay Studio (ASX:SP8) launches Sacre Bleu globally on Nintendo Switch and Steam, marking its first title on these platforms.
CZR Resources Ltd (ASX:CZR) announces a trading halt pending an update on the Robe River Joint Venture offer.
Pilbara Minerals (ASX:PLS) reports March quarter production of 125 kt, reduced revenue, and key project completions.